BIOC - Another Round of Dilution

Surprised by another cash raise by BIOC. After the opening price crash again, and subsequent rise to the low $0.50's, had to take some risk off. Holding a smaller position and may accumulate if price action warrants it. If the company is going to use these funds to expand their burgeoning commercial operations this could be great for future growth. However Biocept Inc. management also stated that this will allow them to be funded through Dec. 2020. So this could be funding to stay alive for a few more months, or a proper cash raise for later explosive growth. JMO GL